Business / Finance

RSS

Mimedx receives subpoena from Office of Inspector General, HHS

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities.

2 Jan 2015

Elements Behavioral Health acquires Park Bench Group Counseling

Elements Behavioral Health, a leading nationwide provider of addiction and mental health treatment programs, announced today that it has acquired Park Bench Group Counseling, located in Southeastern New Jersey.

31 Dec 2014

OncoGenex executes initial agreement with Teva to regain rights to custirsen

OncoGenex Pharmaceuticals, Inc. today announced that it has executed an initial agreement with Teva Pharmaceutical Industries Ltd. to regain rights to custirsen, an investigational compound currently being evaluated in Phase 3 clinical development as a treatment for prostate and lung cancers.

31 Dec 2014

Lightpoint Medical raises $3.1M in Series A financing round for medical imaging technology

Lightpoint Medical, a developer of innovative surgical imaging technologies, announced today that the company has raised £2 million ($3.1 million) in a Series A financing round.

31 Dec 2014

ARC Healthcare declares common stock dividend for January 2015

American Realty Capital Healthcare Trust, Inc. announced today that, pursuant to the prior authorization of its board of directors, on January 15, 2015, ARC Healthcare will pay a distribution of $0.056666667 per share to stockholders of record at the close of business on January 8, 2015.

31 Dec 2014

Tikcro enters into research and license agreement with Yeda

Tikcro Technologies Ltd. today announced that it has entered into a research and license agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science in Israel.

30 Dec 2014

Abbott reports tender offer results to purchase 5.125% Senior Notes issued by CFR International SpA

Abbott today reported early results for the tender offer and related consent solicitation commenced by its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation to purchase for cash any or all of the outstanding 5.125% Senior Notes due 2022 (the "Notes") issued by CFR International SpA, a Chilean corporation and subsidiary of ALH.

30 Dec 2014

Gannett Healthcare Group sold to OnCourse Learning

Gannett Co., Inc. today announced it has sold Gannett Healthcare Group to OnCourse Learning, an online education and training provider.

30 Dec 2014

MagnaChip launches new bio-sensor research collaboration

MagnaChip Semiconductor Corporation, a Korea-based designer and manufacturer of analog and mixed-signal semiconductor products, today announced it has launched a research collaboration focused on developing innovative, cost-effective silicon magnetic bio-sensor technology capable of monitoring extremely rare cells in blood.

30 Dec 2014

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.

29 Dec 2014

Tianyin Pharmaceutical releases unaudited preliminary financial results for Q1 FY 2015

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015.

25 Dec 2014

Vermillion closes previously announced private placement with investors

Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, announced today that the Company closed its previously announced private placement with investors including Oracle Investment Management, Jack W. Schuler, Birchview Fund LLC and several Vermillion directors. Total proceeds were $10.5 million, before offering expenses.

25 Dec 2014

Soligenix closes previously announced registered public offering

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that on December 24, 2014 it closed its previously announced registered public offering.

25 Dec 2014

PlasmaTech Biopharmaceuticals closes underwritten public offering of common stock

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing patient care in critical areas, announced the closing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase up to an aggregate 3,500,000 shares of common stock, at an offering price of $4.00 per share and $.01 per warrant.

25 Dec 2014

IMRIS closes private placement offering of 10,563,380 units

IMRIS Inc. today announced it has closed the private placement offering of 10,563,380 units at an offering price of US$0.284 per unit.

25 Dec 2014

CCG completes $8M in Tax Credits to expand, consolidate healthcare services in Sharon

Commonwealth Cornerstone Group (CCG) today announced the completion of an $8 million New Markets Tax Credits transaction on Tuesday to help fund the expansion and consolidation of healthcare services provided by Primary Health Network (PHN) in Sharon.

25 Dec 2014

Comprehensive analysis of the global composites in orthopedic market

Composites in global orthopedic industry are expected to grow at an average rate of 8.1%. The US has highest consumption in terms of value and volume. Hip, knee and spine surgeries are the common orthopedic procedures in the developed world while in emerging economies they have a lower penetration.

24 Dec 2014

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, announced today the first signed Middle East sales/distribution agreement for lead product Neutrolin with distributor Arabian Trade House in the Kingdom of Saudi Arabia.

23 Dec 2014

Shandong Taibang Biological Products earns GMP certification for new production facility

China Biologic Products, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., has received Good Manufacturing Practices ("GMP") certification from the China Food and Drug Administration (the "CFDA") for its new coagulation factor production facility.

23 Dec 2014

CytoSorbents starts trading on The Nasdaq Capital Market

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".

23 Dec 2014